A Biosimilarity Study Between QX001S and Ustekinumab in Healthy Chinese Male Subjects

Objective: To evaluate the tolerance, variability, and pharmacokinetics (PK) of QX001S, a biosimilar for ustekinumab, in healthy Chinese men.Methods: One hundred and seventy-eight healthy men were recruited in this randomized, double-blind, single-dose, two-arm, parallel study, and received 45 mg of...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Lei Gao, Qingmei Li, Hong Zhang, Min Wu, Min Fang, Lizhi Yang, Xiaojiao Li, Jingrui Liu, Cuiyun Li, Hong Chen, Xiaoxue Zhu, Yanhua Ding, Mingwei Zhou
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Frontiers Media S.A. 2021-05-01
Cyfres:	Frontiers in Pharmacology
Pynciau:	ustekinumab biosimilar immunogenicity pharmacokinetics inter-subject variability
Mynediad Ar-lein:	https://www.frontiersin.org/articles/10.3389/fphar.2021.675358/full
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!